MicroRNAs and lymphomagenesis: A functional review

British Journal of Haematology

Volumn 160, Issue 5, 2013, Pages 571-581

  Lawrie, Charles H ^a,b,c  

^a BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^b BASQUE FOUNDATION FOR SCIENCE   (Spain)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Lymph; Lymphomagenesis; MicroRNA; OncomiR

Indexed keywords

CYCLIN DEPENDENT KINASE 6; GAMMA INTERFERON; INTERLEUKIN 2; JANUS KINASE 2; MICRORNA; MICRORNA 125B; MICRORNA 155; MICRORNA 15A; MICRORNA 16; MICRORNA 17HG; MICRORNA 21; MICRORNA 34A; MYC PROTEIN; PROTEIN BCL 2; PROTEIN MCL 1; PROTEIN P53; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANP32A GENE; APOPTOSIS; AUTOIMMUNITY; B CELL LEUKEMIA; B CELL LYMPHOMA; BREAST CANCER; BURKITT LYMPHOMA; CELL DIFFERENTIATION; CHROMOSOME 13Q; CHROMOSOME 14; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; COLORECTAL CANCER; CYTOKINE PRODUCTION; DNA FLANKING REGION; EXPERIMENTAL MODEL; GENE ACTIVATION; GENE CLUSTER; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCUS; GENE REPRESSION; GENETIC ASSOCIATION; GLIOMA; HEMATOLOGIC MALIGNANCY; HUMAN; IN VIVO STUDY; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; LYMPHOMA; LYMPHOMAGENESIS; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT NEOPLASTIC DISEASE; MANTLE CELL LYMPHOMA; MOUSE STRAIN; NONHODGKIN LYMPHOMA; NONHUMAN; ONCOGENESIS AND MALIGNANT TRANSFORMATION; PATHOGENESIS; PDCD4 GENE; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INDUCTION; PROTEIN TARGETING; PTEN GENE; REVIEW; RNA ANALYSIS; SERPINB5 GENE; SIGNAL TRANSDUCTION; TIMP3 GENE; TPM1 GENE; TUMOR SUPPRESSOR GENE;

ANIMALS; B-LYMPHOCYTES; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA; LYMPHOPOIESIS; MICE; MICE, INBRED NZB; MICE, TRANSGENIC; MICRORNAS; MODELS, GENETIC; RNA, NEOPLASM;

EID: 84873996503     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12157     Document Type: Review

References (124)

1. Agirre, X., Vilas-Zornoza, A., Jimenez-Velasco, A., Martin-Subero, J.I., Cordeu, L., Garate, L., San Jose-Eneriz, E., Abizanda, G., Rodriguez-Otero, P., Fortes, P., Rifon, J., Bandres, E., Calasanz, M.J., Martin, V., Heiniger, A., Torres, A., Siebert, R., Roman-Gomez, J. & Prosper, F. (2009) Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Research, 69, 4443-4453.
2. Alencar, A.J., Malumbres, R., Kozloski, G.A., Advani, R., Talreja, N., Chinichian, S., Briones, J., Natkunam, Y., Sehn, L.H., Gascoyne, R.D., Tibshirani, R. & Lossos, I.S. (2011) MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Clinical Cancer Research, 17, 4125-4135.
3. Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, J. Jr, Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R., Levy, R., Wilson, W., Grever, M.R., Byrd, J.C., Botstein, D., Brown, P.O. & Staudt, L.M. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503-511.
4. Asangani, I.A., Rasheed, S.A., Nikolova, D.A., Leupold, J.H., Colburn, N.H., Post, S. & Allgayer, H. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27, 2128-2136.
5. Babar, I.A., Cheng, C.J., Booth, C.J., Liang, X., Weidhaas, J.B., Saltzman, W.M. & Slack, F.J. (2012) Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proceedings of the National Academy of Sciences of the USA, 109, E1695-E1704.
6. Bagchi, A. & Mills, A.A. (2008) The quest for the 1p36 tumor suppressor. Cancer Research, 68, 2551-2556.
7. Barnes, N.A., Stephenson, S., Cocco, M., Tooze, R.M. & Doody, G.M. (2012) BLIMP-1 and STAT3 counterregulate microRNA-21 during plasma cell differentiation. Journal of Immunology, 189, 253-260.
8. Bezman, N.A., Chakraborty, T., Bender, T. & Lanier, L.L. (2011) miR-150 regulates the development of NK and iNKT cells. Journal of Experimental Medicine, 208, 2717-2731.
9. Boominathan, L. (2010) The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network. Cancer and Metastasis Reviews, 29, 613-639.
10. Bousquet, M., Quelen, C., Rosati, R., Mansat-De Mas, V., La Starza, R., Bastard, C., Lippert, E., Talmant, P., Lafage-Pochitaloff, M., Leroux, D., Gervais, C., Viguie, F., Lai, J.L., Terre, C., Beverlo, B., Sambani, C., Hagemeijer, A., Marynen, P., Delsol, G., Dastugue, N., Mecucci, C. & Brousset, P. (2008) Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. Journal of Experimental Medicine, 205, 2499-2506.
11. Bousquet, M., Harris, M.H., Zhou, B. & Lodish, H.F. (2010) MicroRNA miR-125b causes leukemia. Proceedings of the National Academy of Sciences of the USA, 107, 21558-21563.
12. Brown, J.R., Lawrence, M.S., Hanna, M., Tesar, B., Stojanov, P., Vartanov, A.R., Fernandes, S.M., Sougnez, C., MacConaill, L., Pochet, N., Regev, A., Werner, L., Gabriel, S., Lander, E.S., Neuberg, D., Freedman, A.S., Getz, G. & Wu, C.J. (2011) Novel germline genetic variants associated with familial chronic lymphocytic leukemia (CLL). Blood (Annual ASH Meeting Abstracts), 118, Abstract 465.
13. Bueno, M.J., Gomez de Cedron, M., Gomez-Lopez, G., Perez de Castro, I., Di Lisio, L., Montes-Moreno, S., Martinez, N., Guerrero, M., Sanchez-Martinez, R., Santos, J., Pisano, D.G., Piris, M.A., Fernandez-Piqueras, J. & Malumbres, M. (2011) Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway. Blood, 117, 6255-6266.
14. Calin, G.A., Dumitru, C.D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., Rassenti, L., Kipps, T., Negrini, M., Bullrich, F. & Croce, C.M. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the USA, 99, 15524-15529.
15. Calin, G.A., Sevignani, C., Dumitru, C.D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M. & Croce, C.M. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the USA, 101, 2999-3004.
16. Calin, G.A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S.E., Iorio, M.V., Visone, R., Sever, N.I., Fabbri, M., Iuliano, R., Palumbo, T., Pichiorri, F., Roldo, C., Garzon, R., Sevignani, C., Rassenti, L., Alder, H., Volinia, S., Liu, C.G., Kipps, T.J., Negrini, M. & Croce, C.M. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. New England Journal of Medicine, 353, 1793-1801.
17. Chan, J.A., Krichevsky, A.M. & Kosik, K.S. (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Research, 65, 6029-6033.
18. Chang, T.C., Yu, D., Lee, Y.S., Wentzel, E.A., Arking, D.E., West, K.M., Dang, C.V., Thomas-Tikhonenko, A. & Mendell, J.T. (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nature Genetics, 40, 43-50.
19. Chen, R.W., Bemis, L.T., Amato, C.M., Myint, H., Tran, H., Birks, D.K., Eckhardt, S.G. & Robinson, W.A. (2008) Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood, 112, 822-829.
20. Chim, C.S., Wong, K.Y., Qi, Y., Loong, F., Lam, W.L., Wong, L.G., Jin, D.Y., Costello, J.F. & Liang, R. (2010) Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis, 31, 745-750.
21. Cimmino, A., Calin, G.A., Fabbri, M., Iorio, M.V., Ferracin, M., Shimizu, M., Wojcik, S.E., Aqeilan, R.I., Zupo, S., Dono, M., Rassenti, L., Alder, H., Volinia, S., Liu, C.G., Kipps, T.J., Negrini, M. & Croce, C.M. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proceedings of the National Academy of Sciences of the USA, 102, 13944-13949.
22. Compagno, M., Lim, W.K., Grunn, A., Nandula, S.V., Brahmachary, M., Shen, Q., Bertoni, F., Ponzoni, M., Scandurra, M., Califano, A., Bhagat, G., Chadburn, A., Dalla-Favera, R. & Pasqualucci, L. (2009) Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature, 459, 717-721.
23. Corsten, M.F., Miranda, R., Kasmieh, R., Krichevsky, A.M., Weissleder, R. & Shah, K. (2007) MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Research, 67, 8994-9000.
24. Costinean, S., Zanesi, N., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N. & Croce, C.M. (2006) Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proceedings of the National Academy of Sciences of the USA, 103, 7024-7029.
25. Costinean, S., Sandhu, S.K., Pedersen, I.M., Tili, E., Trotta, R., Perrotti, D., Ciarlariello, D., Neviani, P., Harb, J., Kauffman, L.R., Shidham, A. & Croce, C.M. (2009) Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. Blood, 114, 1374-1382.
26. Craig, V.J., Cogliatti, S.B., Imig, J., Renner, C., Neuenschwander, S., Rehrauer, H., Schlapbach, R., Dirnhofer, S., Tzankov, A. & Muller, A. (2011) Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1. Blood, 117, 6227-6236.
27. Craig, V.J., Tzankov, A., Flori, M., Schmid, C.A., Bader, A.G. & Muller, A. (2012) Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia, 26, 2421-2424.
28. Dagan, L.N., Jiang, X., Bhatt, S., Cubedo, E., Rajewsky, K. & Lossos, I.S. (2012) miR-155 regulates HGAL expression and increases lymphoma cell motility. Blood, 119, 513-520.
29. Dejean, E., Renalier, M.H., Foisseau, M., Agirre, X., Joseph, N., de Paiva, G.R., Al Saati, T., Soulier, J., Desjobert, C., Lamant, L., Prosper, F., Felsher, D.W., Cavaille, J., Prats, H., Delsol, G., Giuriato, S. & Meggetto, F. (2011) Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. Leukemia, 25, 1882-1890.
30. Di Lisio, L., Sanchez-Beato, M., Gomez-Lopez, G., Rodriguez, M.E., Montes-Moreno, S., Mollejo, M., Menarguez, J., Martinez, M.A., Alves, F.J., Pisano, D.G., Piris, M.A. & Martinez, N. (2012) MicroRNA signatures in B-cell lymphomas. Blood Cancer Journal, 2, e57.
31. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A. Jr, Butel, J.S. & Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
32. Dorsett, Y., McBride, K.M., Jankovic, M., Gazumyan, A., Thai, T.H., Robbiani, D.F., Di Virgilio, M., Reina San-Martin, B., Heidkamp, G., Schwickert, T.A., Eisenreich, T., Rajewsky, K. & Nussenzweig, M.C. (2008) MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity, 28, 630-638.
33. Eis, P.S., Tam, W., Sun, L., Chadburn, A., Li, Z., Gomez, M.F., Lund, E. & Dahlberg, J.E. (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proceedings of the National Academy of Sciences of the USA, 102, 3627-3632.
34. Enomoto, Y., Kitaura, J., Hatakeyama, K., Watanuki, J., Akasaka, T., Kato, N., Shimanuki, M., Nishimura, K., Takahashi, M., Taniwaki, M., Haferlach, C., Siebert, R., Dyer, M.J., Asou, N., Aburatani, H., Nakakuma, H., Kitamura, T. & Sonoki, T. (2011) Emu/miR-125b transgenic mice develop lethal B-cell malignancies. Leukemia, 25, 1849-1856.
35. Fabbri, M., Bottoni, A., Shimizu, M., Spizzo, R., Nicoloso, M.S., Rossi, S., Barbarotto, E., Cimmino, A., Adair, B., Wojcik, S.E., Valeri, N., Calore, F., Sampath, D., Fanini, F., Vannini, I., Musuraca, G., Dell'Aquila, M., Alder, H., Davuluri, R.V., Rassenti, L.Z., Negrini, M., Nakamura, T., Amadori, D., Kay, N.E., Rai, K.R., Keating, M.J., Kipps, T.J., Calin, G.A. & Croce, C.M. (2011) Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. Journal of the American Medical Association, 305, 59-67.
36. Felli, N., Fontana, L., Pelosi, E., Botta, R., Bonci, D., Facchiano, F., Liuzzi, F., Lulli, V., Morsilli, O., Santoro, S., Valtieri, M., Calin, G.A., Liu, C.G., Sorrentino, A., Croce, C.M. & Peschle, C. (2005) MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proceedings of the National Academy of Sciences of the USA, 102, 18081-18086.
37. Friedman, R.C., Farh, K.K., Burge, C.B. & Bartel, D.P. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Research, 19, 92-105.
38. Fujita, S., Ito, T., Mizutani, T., Minoguchi, S., Yamamichi, N., Sakurai, K. & Iba, H. (2008) miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. Journal of Molecular Biology, 378, 492-504.
39. Fulci, V., Chiaretti, S., Goldoni, M., Azzalin, G., Carucci, N., Tavolaro, S., Castellano, L., Magrelli, A., Citarella, F., Messina, M., Maggio, R., Peragine, N., Santangelo, S., Mauro, F.R., Landgraf, P., Tuschl, T., Weir, D.B., Chien, M., Russo, J.J., Ju, J., Sheridan, R., Sander, C., Zavolan, M., Guarini, A., Foa, R. & Macino, G. (2007) Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood, 109, 4944-4951.
40. Gabriely, G., Wurdinger, T., Kesari, S., Esau, C.C., Burchard, J., Linsley, P.S. & Krichevsky, A.M. (2008) MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Molecular and Cellular Biology, 28, 5369-5380.
41. Gao, P., Tchernyshyov, I., Chang, T.C., Lee, Y.S., Kita, K., Ochi, T., Zeller, K.I., De Marzo, A.M., Van Eyk, J.E., Mendell, J.T. & Dang, C.V. (2009) c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature, 458, 762-765.
42. Garofalo, M., Di Leva, G., Romano, G., Nuovo, G., Suh, S.S., Ngankeu, A., Taccioli, C., Pichiorri, F., Alder, H., Secchiero, P., Gasparini, P., Gonelli, A., Costinean, S., Acunzo, M., Condorelli, G. & Croce, C.M. (2009) miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell, 16, 498-509.
43. Gatto, G., Rossi, A., Rossi, D., Kroening, S., Bonatti, S. & Mallardo, M. (2008) Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Research, 36, 6608-6619.
44. Ghisi, M., Corradin, A., Basso, K., Frasson, C., Serafin, V., Mukherjee, S., Mussolin, L., Ruggero, K., Bonanno, L., Guffanti, A., De Bellis, G., Gerosa, G., Stellin, G., D'Agostino, D.M., Basso, G., Bronte, V., Indraccolo, S., Amadori, A. & Zanovello, P. (2011) Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood, 117, 7053-7062.
45. Gottwein, E., Mukherjee, N., Sachse, C., Frenzel, C., Majoros, W.H., Chi, J.T., Braich, R., Manoharan, M., Soutschek, J., Ohler, U. & Cullen, B.R. (2007) A viral microRNA functions as an orthologue of cellular miR-155. Nature, 450, 1096-1099.
46. Griffiths-Jones, S., Grocock, R.J., van Dongen, S., Bateman, A. & Enright, A.J. (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Research, 34, D140-D144.
47. Hans, C.P., Weisenburger, D.D., Greiner, T.C., Gascoyne, R.D., Delabie, J., Ott, G., Muller-Hermelink, H.K., Campo, E., Braziel, R.M., Jaffe, E.S., Pan, Z., Farinha, P., Smith, L.M., Falini, B., Banham, A.H., Rosenwald, A., Staudt, L.M., Connors, J.M., Armitage, J.O. & Chan, W.C. (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 103, 275-282.
48. He, L., Thomson, J.M., Hemann, M.T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S.W., Hannon, G.J. & Hammond, S.M. (2005) A microRNA polycistron as a potential human oncogene. Nature, 435, 828-833.
49. He, L., He, X., Lim, L.P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., Jackson, A.L., Linsley, P.S., Chen, C., Lowe, S.W., Cleary, M.A. & Hannon, G.J. (2007) A microRNA component of the p53 tumour suppressor network. Nature, 447, 1130-1134.
50. Hu, W., Chan, C.S., Wu, R., Zhang, C., Sun, Y., Song, J.S., Tang, L.H., Levine, A.J. & Feng, Z. (2010) Negative regulation of tumor suppressor p53 by microRNA miR-504. Molecular Cell, 38, 689-699.
51. Huang, X., Shen, Y., Liu, M., Bi, C., Jiang, C., Iqbal, J., McKeithan, T.W., Chan, W.C., Ding, S.J. & Fu, K. (2012) Quantitative Proteomics Reveals that miR-155 Regulates the PI3K-AKT Pathway in Diffuse Large B-Cell Lymphoma. American Journal of Pathology, 181, 26-33.
52. Hummel, R., Hussey, D.J. & Haier, J. (2010) MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. European Journal of Cancer, 46, 298-311.
53. Iorio, M.V. & Croce, C.M. (2009) MicroRNAs in cancer: small molecules with a huge impact. Journal of Clinical Oncology, 27, 5848-5856.
54. Jacks, T., Remington, L., Williams, B.O., Schmitt, E.M., Halachmi, S., Bronson, R.T. & Weinberg, R.A. (1994) Tumor spectrum analysis in p53-mutant mice. Current Biology, 4, 1-7.
55. Kim, V.N. (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nature Reviews Molecular Cell Biology, 6, 376-385.
56. Kim, S.W., Ramasamy, K., Bouamar, H., Lin, A.P., Jiang, D. & Aguiar, R.C. (2012) MicroRNAs miR-125a and miR-125b constitutively activate the NF-kappaB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proceedings of the National Academy of Sciences of the USA, 109, 7865-7870.
57. Klein, U., Lia, M., Crespo, M., Siegel, R., Shen, Q., Mo, T., Ambesi-Impiombato, A., Califano, A., Migliazza, A., Bhagat, G. & Dalla-Favera, R. (2010) The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell, 17, 28-40.
58. Kluiver, J., Poppema, S., de Jong, D., Blokzijl, T., Harms, G., Jacobs, S., Kroesen, B.J. & van den Berg, A. (2005) BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. Journal of Pathology, 207, 243-249.
59. Kluiver, J., Haralambieva, E., de Jong, D., Blokzijl, T., Jacobs, S., Kroesen, B.J., Poppema, S. & van den Berg, A. (2006) Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer, 45, 147-153.
60. Kumar, M., Lu, Z., Takwi, A.A., Chen, W., Callander, N.S., Ramos, K.S., Young, K.H. & Li, Y. (2011) Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogene, 30, 843-853.
61. Lawrie, C.H. (2008) microRNA expression in lymphoid malignancies: new hope for diagnosis and therapy? Journal of Cellular and Molecular Medicine, 12, 1432-1444.
62. Lawrie, C.H., Soneji, S., Marafioti, T., Cooper, C.D., Palazzo, S., Paterson, J.C., Cattan, H., Enver, T., Mager, R., Boultwood, J., Wainscoat, J.S. & Hatton, C.S. (2007) MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. International Journal of Cancer, 121, 1156-1161.
63. Lawrie, C.H., Ballabio, E., Dyar, O.J., Jones, M., Ventura, R., Chi, J., Tramonti, D., Gooding, S., Boultwood, J., Wainscoat, J.S., Hatton, C.S. & Schuh, A. (2009) MicroRNA expression in chronic lymphocytic leukaemia. British Journal of Haematology, 147, 398-402.
64. Le, M.T., Shyh-Chang, N., Khaw, S.L., Chin, L., Teh, C., Tay, J., O'Day, E., Korzh, V., Yang, H., Lal, A., Lieberman, J., Lodish, H.F. & Lim, B. (2011) Conserved regulation of p53 network dosage by microRNA-125b occurs through evolving miRNA-target gene pairs. PLoS Genetics, 7, e1002242.
65. Lenz, G., Wright, G.W., Emre, N.C., Kohlhammer, H., Dave, S.S., Davis, R.E., Carty, S., Lam, L.T., Shaffer, A.L., Xiao, W., Powell, J., Rosenwald, A., Ott, G., Muller-Hermelink, H.K., Gascoyne, R.D., Connors, J.M., Campo, E., Jaffe, E.S., Delabie, J., Smeland, E.B., Rimsza, L.M., Fisher, R.I., Weisenburger, D.D., Chan, W.C. & Staudt, L.M. (2008) Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proceedings of the National Academy of Sciences of the USA, 105, 13520-13525.
66. Leucci, E., Cocco, M., Onnis, A., De Falco, G., van Cleef, P., Bellan, C., van Rijk, A., Nyagol, J., Byakika, B., Lazzi, S., Tosi, P., van Krieken, H. & Leoncini, L. (2008) MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. Journal of Pathology, 216, 440-450.
67. Leucci, E., Zriwil, A., Gregersen, L.H., Jensen, K.T., Obad, S., Bellan, C., Leoncini, L., Kauppinen, S. & Lund, A.H. (2012) Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo. Oncogene, Epub ahead of print, doi: 10.1038/onc.2012.15.
68. Lia, M., Carette, A., Tang, H., Shen, Q., Mo, T., Bhagat, G., Dalla-Favera, R. & Klein, U. (2012) Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines. Blood, 119, 2981-2990.
69. Lin, J., Lwin, T., Zhao, J.J., Tam, W., Choi, Y.S., Moscinski, L.C., Dalton, W.S., Sotomayor, E.M., Wright, K.L. & Tao, J. (2011) Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas. Leukemia, 25, 145-152.
70. Liu, Y., Corcoran, M., Rasool, O., Ivanova, G., Ibbotson, R., Grander, D., Iyengar, A., Baranova, A., Kashuba, V., Merup, M., Wu, X., Gardiner, A., Mullenbach, R., Poltaraus, A., Hultstrom, A.L., Juliusson, G., Chapman, R., Tiller, M., Cotter, F., Gahrton, G., Yankovsky, N., Zabarovsky, E., Einhorn, S. & Oscier, D. (1997) Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene, 15, 2463-2473.
71. Lodygin, D., Tarasov, V., Epanchintsev, A., Berking, C., Knyazeva, T., Korner, H., Knyazev, P., Diebold, J. & Hermeking, H. (2008) Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle, 7, 2591-2600.
72. Loffler, D., Brocke-Heidrich, K., Pfeifer, G., Stocsits, C., Hackermuller, J., Kretzschmar, A.K., Burger, R., Gramatzki, M., Blumert, C., Bauer, K., Cvijic, H., Ullmann, A.K., Stadler, P.F. & Horn, F. (2007) Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood, 110, 1330-1333.
73. Malumbres, R., Sarosiek, K.A., Cubedo, E., Ruiz, J.W., Jiang, X., Gascoyne, R.D., Tibshirani, R. & Lossos, I.S. (2009) Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood, 113, 3754-3764.
74. Manfe, V., Biskup, E., Rosbjerg, A., Kamstrup, M., Skov, A.G., Lerche, C.M., Lauenborg, B.T., Odum, N. & Gniadecki, R. (2012) miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma. PLoS ONE, 7, e29541.
75. Medina, P.P., Nolde, M. & Slack, F.J. (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature, 467, 86-90.
76. Melzner, I., Weniger, M.A., Menz, C.K. & Moller, P. (2006) Absence of the JAK2 V617F activating mutation in classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma. Leukemia, 20, 157-158.
77. Meng, F., Henson, R., Wehbe-Janek, H., Ghoshal, K., Jacob, S.T. & Patel, T. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133, 647-658.
78. Merkel, O., Asslaber, D., Pinon, J.D., Egle, A. & Greil, R. (2010) Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia. Cell Cycle, 9, 2764-2768.
79. Muto, T., Okazaki, I.M., Yamada, S., Tanaka, Y., Kinoshita, K., Muramatsu, M., Nagaoka, H. & Honjo, T. (2006) Negative regulation of activation-induced cytidine deaminase in B cells. Proceedings of the National Academy of Sciences of the USA, 103, 2752-2757.
80. Navarro, A., Gaya, A., Martinez, A., Urbano-Ispizua, A., Pons, A., Balague, O., Gel, B., Abrisqueta, P., Lopez-Guillermo, A., Artells, R., Montserrat, E. & Monzo, M. (2008) MicroRNA expression profiling in classic Hodgkin lymphoma. Blood, 111, 2825-2832.
81. Navarro, A., Diaz, T., Martinez, A., Gaya, A., Pons, A., Gel, B., Codony, C., Ferrer, G., Martinez, C., Montserrat, E. & Monzo, M. (2009) Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. Blood, 114, 2945-2951.
82. Nie, K., Gomez, M., Landgraf, P., Garcia, J.F., Liu, Y., Tan, L.H., Chadburn, A., Tuschl, T., Knowles, D.M. & Tam, W. (2008) MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. American Journal of Pathology, 173, 242-252.
83. O'Connell, R.M., Rao, D.S., Chaudhuri, A.A., Boldin, M.P., Taganov, K.D., Nicoll, J., Paquette, R.L. & Baltimore, D. (2008) Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. Journal of Experimental Medicine, 205, 585-594.
84. O'Connell, R.M., Chaudhuri, A.A., Rao, D.S. & Baltimore, D. (2009) Inositol phosphatase SHIP1 is a primary target of miR-155. Proceedings of the National Academy of Sciences of the USA, 106, 7113-7118.
85. O'Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V. & Mendell, J.T. (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 435, 839-843.
86. Olive, V., Bennett, M.J., Walker, J.C., Ma, C., Jiang, I., Cordon-Cardo, C., Li, Q.J., Lowe, S.W., Hannon, G.J. & He, L. (2009) miR-19 is a key oncogenic component of mir-17-92. Genes & Development, 23, 2839-2849.
87. Ooi, A.G., Sahoo, D., Adorno, M., Wang, Y., Weissman, I.L. & Park, C.Y. (2010) MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets. Proceedings of the National Academy of Sciences of the USA, 107, 21505-21510.
88. Ouillette, P., Erba, H., Kujawski, L., Kaminski, M., Shedden, K. & Malek, S.N. (2008) Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Cancer Research, 68, 1012-1021.
89. Papagiannakopoulos, T., Shapiro, A. & Kosik, K.S. (2008) MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Research, 68, 8164-8172.
90. Pedersen, I.M., Otero, D., Kao, E., Miletic, A.V., Hother, C., Ralfkiaer, E., Rickert, R.C., Gronbaek, K. & David, M. (2009) Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. EMBO Molecular Medicine, 1, 288-295.
91. Pfeifer, D., Pantic, M., Skatulla, I., Rawluk, J., Kreutz, C., Martens, U.M., Fisch, P., Timmer, J. & Veelken, H. (2007) Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood, 109, 1202-1210.
92. Pichiorri, F., Suh, S.S., Ladetto, M., Kuehl, M., Palumbo, T., Drandi, D., Taccioli, C., Zanesi, N., Alder, H., Hagan, J.P., Munker, R., Volinia, S., Boccadoro, M., Garzon, R., Palumbo, A., Aqeilan, R.I. & Croce, C.M. (2008) MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proceedings of the National Academy of Sciences of the USA, 105, 12885-12890.
93. Rai, D., Kim, S.W., McKeller, M.R., Dahia, P.L. & Aguiar, R.C. (2010) Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proceedings of the National Academy of Sciences of the USA, 107, 3111-3116.
94. Rao, E., Jiang, C., Ji, M., Huang, X., Iqbal, J., Lenz, G., Wright, G., Staudt, L.M., Zhao, Y., McKeithan, T.W., Chan, W.C. & Fu, K. (2012) The miRNA-17 approximately 92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. Leukemia, 26, 1064-1072.
95. Raveche, E.S., Salerno, E., Scaglione, B.J., Manohar, V., Abbasi, F., Lin, Y.C., Fredrickson, T., Landgraf, P., Ramachandra, S., Huppi, K., Toro, J.R., Zenger, V.E., Metcalf, R.A. & Marti, G.E. (2007) Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood, 109, 5079-5086.
96. Rodriguez, A., Vigorito, E., Clare, S., Warren, M.V., Couttet, P., Soond, D.R., van Dongen, S., Grocock, R.J., Das, P.P., Miska, E.A., Vetrie, D., Okkenhaug, K., Enright, A.J., Dougan, G., Turner, M. & Bradley, A. (2007) Requirement of bic/microRNA-155 for normal immune function. Science, 316, 608-611.
97. Scaglione, B.J., Salerno, E., Balan, M., Coffman, F., Landgraf, P., Abbasi, F., Kotenko, S., Marti, G.E. & Raveche, E.S. (2007) Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model. British Journal of Haematology, 139, 645-657.
98. Schramedei, K., Morbt, N., Pfeifer, G., Lauter, J., Rosolowski, M., Tomm, J.M., von Bergen, M., Horn, F. & Brocke-Heidrich, K. (2011) MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4. Oncogene, 30, 2975-2985.
99. Si, M.L., Zhu, S., Wu, H., Lu, Z., Wu, F. & Mo, Y.Y. (2007) miR-21-mediated tumor growth. Oncogene, 26, 2799-2803.
100. Sonoki, T., Iwanaga, E., Mitsuya, H. & Asou, N. (2005) Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia. Leukemia, 19, 2009-2010.
101. Sotillo, E., Laver, T., Mellert, H., Schelter, J.M., Cleary, M.A., McMahon, S. & Thomas-Tikhonenko, A. (2011) Myc overexpression brings out unexpected antiapoptotic effects of miR-34a. Oncogene, 30, 2587-2594.
102. Tagawa, H., Karube, K., Tsuzuki, S., Ohshima, K. & Seto, M. (2007) Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development. Cancer Science, 98, 1482-1490.
103. Thai, T.H., Calado, D.P., Casola, S., Ansel, K.M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J.L., Schmidt-Supprian, M., Rajewsky, N., Yancopoulos, G., Rao, A. & Rajewsky, K. (2007) Regulation of the germinal center response by microRNA-155. Science, 316, 604-608.
104. Thompson, R.C., Herscovitch, M., Zhao, I., Ford, T.J. & Gilmore, T.D. (2011) NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway. Journal of Biological Chemistry, 286, 1675-1682.
105. Tian, S., Huang, S., Wu, S., Guo, W., Li, J. & He, X. (2010) MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3′ untranslated region. Biochemical and Biophysical Research Communications, 396, 435-439.
106. Ventura, A., Young, A.G., Winslow, M.M., Lintault, L., Meissner, A., Erkeland, S.J., Newman, J., Bronson, R.T., Crowley, D., Stone, J.R., Jaenisch, R., Sharp, P.A. & Jacks, T. (2008) Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell, 132, 875-886.
107. Vigorito, E., Perks, K.L., Abreu-Goodger, C., Bunting, S., Xiang, Z., Kohlhaas, S., Das, P.P., Miska, E.A., Rodriguez, A., Bradley, A., Smith, K.G., Rada, C., Enright, A.J., Toellner, K.M., Maclennan, I.C. & Turner, M. (2007) microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity, 27, 847-859.
108. Volinia, S., Calin, G.A., Liu, C.G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., Prueitt, R.L., Yanaihara, N., Lanza, G., Scarpa, A., Vecchione, A., Negrini, M., Harris, C.C. & Croce, C.M. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences of the USA, 103, 2257-2261.
109. Wang, M., Tan, L., Dijkstra, M., van Lom, K., Robertus, J.L., Harms, G., Blokzijl, T., Kooistra, K., van T'veer, M., Rosati, S., Visser, L., Jongen-Lavrencic, M., Kluin, P. & van den Berg, A. (2008) miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. Journal of Pathology, 215, 13-20.
110. Wang, X., Li, C., Ju, S., Wang, Y., Wang, H. & Zhong, R. (2011) Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation. Leukaemia & Lymphoma, 52, 1991-1998.
111. Watanabe, A., Tagawa, H., Yamashita, J., Teshima, K., Nara, M., Iwamoto, K., Kume, M., Kameoka, Y., Takahashi, N., Nakagawa, T., Shimizu, N. & Sawada, K. (2011) The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia, 25, 1324-1334.
112. Westin, J.R. & Fayad, L.E. (2009) Beyond R-CHOP and the IPI in large-cell lymphoma: molecular markers as an opportunity for stratification. Current Hematologic Malignancy Reports, 4, 218-224.
113. Woods, K., Thomson, J.M. & Hammond, S.M. (2007) Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. Journal of Biological Chemistry, 282, 2130-2134.
114. Xiao, C., Calado, D.P., Galler, G., Thai, T.H., Patterson, H.C., Wang, J., Rajewsky, N., Bender, T.P. & Rajewsky, K. (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell, 131, 146-159.
115. Xiao, C., Srinivasan, L., Calado, D.P., Patterson, H.C., Zhang, B., Wang, J., Henderson, J.M., Kutok, J.L. & Rajewsky, K. (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nature Immunology, 9, 405-414.
116. Yamakuchi, M. & Lowenstein, C.J. (2009) MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle, 8, 712-715.
117. Yamanaka, Y., Tagawa, H., Takahashi, N., Watanabe, A., Guo, Y.M., Iwamoto, K., Yamashita, J., Saitoh, H., Kameoka, Y., Shimizu, N., Ichinohasama, R. & Sawada, K. (2009) Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. Blood, 114, 3265-3275.
118. Yan, H.L., Xue, G., Mei, Q., Wang, Y.Z., Ding, F.X., Liu, M.F., Lu, M.H., Tang, Y., Yu, H.Y. & Sun, S.H. (2009) Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO Journal, 28, 2719-2732.
119. Ye, B.H., Lista, F., Lo Coco, F., Knowles, D.M., Offit, K., Chaganti, R.S. & Dalla-Favera, R. (1993) Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science, 262, 747-750.
120. de Yebenes, V.G., Belver, L., Pisano, D.G., Gonzalez, S., Villasante, A., Croce, C., He, L. & Ramiro, A.R. (2008) miR-181b negatively regulates activation-induced cytidine deaminase in B cells. Journal of Experimental Medicine, 205, 2199-2206.
121. Zhang, J., Jima, D.D., Jacobs, C., Fischer, R., Gottwein, E., Huang, G., Lugar, P.L., Lagoo, A.S., Rizzieri, D.A., Friedman, D.R., Weinberg, J.B., Lipsky, P.E. & Dave, S.S. (2009) Patterns of microRNA expression characterize stages of human B cell differentiation. Blood, 113, 4586-4594.
122. Zhang, X., Chen, X., Lin, J., Lwin, T., Wright, G., Moscinski, L.C., Dalton, W.S., Seto, E., Wright, K., Sotomayor, E. & Tao, J. (2012) Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas. Oncogene, 31, 3002-3008.
123. Zhao, Y., Xu, H., Yao, Y., Smith, L.P., Kgosana, L., Green, J., Petherbridge, L., Baigent, S.J. & Nair, V. (2011) Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas. PLoS Pathogens, 7, e1001305.
124. Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S. & Mo, Y.Y. (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Research, 18, 350-359.